STOCK TITAN
  1. Home
  2. Sec-filings
  3. NUTX
  4. [Form 4] Nutex Health Inc. Insider Trading Activity

Nutex Health (NUTX) CEO Vo adds 184,071 shares and exercises 4,841 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nutex Health Inc. director and CEO Thomas T. Vo reported two insider equity transactions. First, an entity he owns and controls, Micro Hospital Holdings LLC, received 184,071 shares of common stock in a private issuance. These shares relate to Vo’s pro-rata interest in two under-construction hospitals previously transferred to Nutex Health Holdco LLC under an Agreement and Plan of Merger. Following this issuance, Micro Hospital Holdings LLC holds 2,027,267 common shares indirectly for Vo.

Separately, Vo exercised 4,841 restricted stock units (RSUs) into an equal number of common shares at a stated price of $0.00 per share, with 16,507 RSUs shown as beneficially owned afterward. The Form 4 also corrects the previously reported RSU balance from an earlier filing.

Positive

  • None.

Negative

  • None.
Insider Vo Thomas T.
Role Chief Executive Officer
Type Security Shares Price Value
Other Common Stock 184,071 $0.00 --
Exercise Restricted Stock Units 4,841 $0.00 --
Holdings After Transaction: Common Stock — 2,027,267 shares (Indirect, By Micro Hospital Holdings LLC); Restricted Stock Units — 16,507 shares (Direct)
Footnotes (1)
  1. Represents the issuance in private transaction of 95,076 and 88,995 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of two under construction hospitals previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026. Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein. This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.
Private issuance shares 184,071 shares Common stock issued in private transaction to Micro Hospital Holdings LLC
Indirect common shares after transaction 2,027,267 shares Common stock held by Micro Hospital Holdings LLC following issuance
RSUs exercised 4,841 units Restricted Stock Units converted into common stock at $0.00 per share
RSUs beneficially owned after grant 16,507 units Restricted Stock Units reported as beneficially owned after March 10, 2026 grant
Restructuring shares total 184,071 shares Shares tied to obligations for two under-construction hospitals
Restricted Stock Units financial
"The filing reports a transaction involving 4,841 Restricted Stock Units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Agreement and Plan of Merger financial
"Obligations arose under the Agreement and Plan of Merger dated November 23, 2021."
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
private transaction financial
"Represents the issuance in private transaction of 95,076 and 88,995 shares of common stock."
A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.
beneficially owned financial
"This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Restricted stock units (RSUs) financial
"Corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Vo Thomas T.
(Last)(First)(Middle)
1776 YORKTOWN STREET SUITE 700
C/O NUTEX HEALTH INC.
(Street)
HOUSTON TEXAS 77056
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/09/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/09/2026J184,071A$0(1)2,027,267IBy Micro Hospital Holdings LLC(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$003/10/2026M4,84103/01/202603/01/2029Common Stock4,841$016,507(3)D
Explanation of Responses:
1. Represents the issuance in private transaction of 95,076 and 88,995 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of two under construction hospitals previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.
2. Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein.
3. This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.
/s/ Thomas Vo04/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Nutex Health (NUTX) report for Thomas T. Vo?

Nutex Health reported that Thomas T. Vo’s controlled entity received 184,071 common shares in a private issuance, and Vo separately exercised 4,841 RSUs into common stock. These actions increased his indirect and direct equity exposure without open-market buying or selling.

How many Nutex Health (NUTX) shares does Micro Hospital Holdings LLC now own?

After the reported private issuance, Micro Hospital Holdings LLC holds 2,027,267 Nutex Health common shares. The Form 4 states that Thomas T. Vo owns and controls this LLC, making these shares part of his indirect beneficial ownership position in the company.

What is the nature of the 184,071-share issuance reported by Nutex Health (NUTX)?

The 184,071 common shares represent a private issuance tied to Nutex Health’s one-time obligations for Vo’s pro-rata share of two under-construction hospitals. These obligations arose from an Agreement and Plan of Merger referenced in Nutex Health’s proxy statement and Form 10-K.

Did the Nutex Health (NUTX) Form 4 involve any open-market stock sales or purchases?

The Form 4 does not show any open-market purchases or sales. Instead, it reports a private issuance of 184,071 common shares to an LLC controlled by Thomas Vo and a derivative exercise where 4,841 RSUs converted into common stock at a stated price of $0.00.